# ROCURONIUM BROMIDE
> **NDA217472** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2025-06-09
## Drug
- **FDA Application Number:** NDA217472
- **Application type:** New Drug Application
- **Brand name:** ROCURONIUM BROMIDE
- **Generic name:** ROCURONIUM BROMIDE
- **Active ingredients:** ROCURONIUM BROMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2025-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217472)
---
*AI Analytics · CC0 1.0*